CAS 61596-53-0

formulación de pre-liposomas 1

Descripción:

formulación de pre-liposomas 1, identificado por el número CAS 61596-53-0, es un tipo de sistema de entrega basado en lípidos diseñado para encapsular y transportar agentes terapéuticos, particularmente en aplicaciones farmacéuticas. Esta formulación típicamente consiste en fosfolípidos y otros excipientes que facilitan la formación de liposomas al ser hidratados. Las características de los pre-liposomas incluyen su capacidad para mejorar la solubilidad y estabilidad de los fármacos hidrofóbicos, mejorar la biodisponibilidad y proporcionar perfiles de liberación controlada. A menudo se caracterizan por su tamaño, que puede variar desde nanómetros hasta micrómetros, y su carga superficial, que influye en su interacción con las membranas biológicas. Además, los pre-liposomas pueden ser diseñados para lograr cinéticas de liberación específicas y capacidades de direccionamiento, lo que los hace versátiles para diversas aplicaciones de entrega de medicamentos. La formulación es generalmente estable en condiciones secas y requiere hidratación para formar liposomas, que luego pueden encapsular ingredientes farmacéuticos activos. En general, los pre-liposomas representan un enfoque prometedor en el campo de los sistemas de entrega de medicamentos.

Fórmula: C₄₈H₉₆NO₈P

3,5,9-Trioxa-4-phosphanonacosan-1-aminium,4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoeicosyl)oxy]-, inner salt,4-oxide, (7R)-

CAS: 61596-53-0

Fórmula: C₄₈H₉₆NO₈P

Pureza: 98%

Forma y color: Solid

Peso molecular: 846.2515

Ref: IN-DA00IAW7

(R)-2,3-Bis(icosanoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate

CAS: 61596-53-0

(R)-2,3-Bis(icosanoyloxy)propyl (2-(trimethylammonio)ethyl) phosphate

Pureza: 98%

Peso molecular: 846.27g/mol

Ref: 54-OR1067498

1,2-Diarachidoyl-sn-Glycero-3-Phosphatidylcholine

CAS: 61596-53-0

Fórmula: C48H96NO8P

Pureza: >99%

Forma y color: Solid

Peso molecular: 846.25

Ref: 48-37-2000

1,2-Diarachidoyl-sn-glycero-3-phosphocholine

CAS: 61596-53-0

1,2-Diarachidoyl-sn-glycero-3-phosphocholine is a polyunsaturated fatty acid that belongs to the group of phospholipids. It is found in plasma samples and has been shown to be involved in the regulation of cellular physiology. This compound has been identified as a potential marker for cardiovascular disease through its ability to reduce the risk of heart attack or stroke. The 1,2-diarachidoyl-sn-glycero-3-phosphocholine molecule contains two acyl chains, which are linked by ester bonds, and hydroxyl groups on either end of the molecule. The molecular modeling studies have revealed that this compound can exist in three conformations: bent (A), linear (B), or extended (C). In this study, it was found that conformational A was most prevalent in both hydrated and nonhydrated states.

Fórmula: C₄₈H₉₆NO₈P

Pureza: Reported

Peso molecular: 846.28 g/mol

Ref: 3D-FD172067

1,2-Diarachidoyl-sn-glycero-3-phosphocholine

CAS: 61596-53-0

1,2-Diarachidoyl-sn-glycero-3-phosphocholine (DAGPC) is a phospholipid compound that plays a crucial role in various biological processes. It acts as an interfacial agent, forming a protein complex at the cell membrane. DAGPC has been studied extensively in relation to breast cancer, cardiac health, diabetes, and other conditions. In experiments conducted on animals and human subjects, it has been shown to have potential benefits in regulating angiotensin-converting enzyme activity, supporting myocardial function, and controlling glucagon levels. Additionally, DAGPC has demonstrated promising effects in castration-induced prostate cancer models. Its unique properties make it a valuable compound for further research and potential therapeutic applications.

Fórmula: C₄₈H₉₆NO₈P

Peso molecular: 846.28 g/mol

Ref: 3D-D-1422